Bioregenx annual operating expenses
2021
2022
2023
2024
2025
Bioregenx Operating Expenses Growth & History (BRGX)
Bioregenx's operating expenses was $2.7M for fiscal 2025.
View full Bioregenx company overviewBioregenx annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.7M | −$21.7M | −88.75% |
| 2024 | 2024-12-31 | $24.4M | $18.7M | +326.93% |
| 2023 | 2023-12-31 | $5.7M | $5.6M | +4648.41% |
| 2022 | 2022-12-31 | $120,467 | −$242,681 | −66.83% |
| 2021 | 2021-12-31 | $363,148 | — | — |
Bioregenx quarterly operating expenses
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $398,052 | −$200,594 | −33.51% |
| Q4 2025 | 2025-12-31 | $1.3M | −$17.4M | −93.27% |
| Q3 2025 | 2025-09-30 | $434,856 | −$374,099 | −46.24% |
| Q2 2025 | 2025-06-30 | $459,715 | −$1.0M | −69.55% |
| Q1 2025 | 2025-03-31 | $598,646 | −$2.9M | −82.72% |
| Q4 2024 | 2024-12-31 | $18.6M | $18.0M | +3061.49% |
| Q3 2024 | 2024-09-30 | $808,955 | −$2.2M | −73.39% |
| Q2 2024 | 2024-06-30 | $1.5M | $366,745 | +32.09% |
| Q1 2024 | 2024-03-31 | $3.5M | $2.5M | +265.36% |
| Q4 2023 | 2023-12-31 | $589,581 | $575,132 | +3980.43% |
| Q3 2023 | 2023-09-30 | $3.0M | $3.0M | +22460.15% |
| Q2 2023 | 2023-06-30 | $1.1M | $1.1M | +2305.11% |
| Q1 2023 | 2023-03-31 | $947,997 | $902,974 | +2005.58% |
| Q4 2022 | 2022-12-31 | $14,449 | — | — |
| Q3 2022 | 2022-09-30 | $13,474 | — | — |
| Q2 2022 | 2022-06-30 | $47,521 | — | — |
| Q1 2022 | 2022-03-31 | $45,023 | — | — |
Bioregenx operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Bioregenx's operating expenses increased from $363,148 to $2.7M, a change of $2.4M. The latest reported quarter, Q1 2026, shows $398,052.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioregenx source filings ↗